| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |